Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.37 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.37 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | CNR2 | P34972 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6161512 | 0.80 | NPC1 (0.33) | NPC1RAB9AMAPK1SMN1; SMN2LMNA | |
| SCHEMBL6163116 | 0.76 | NR1I2 (0.40) | NPC1RAB9ALMNACASP3SENP8 | |
| SCHEMBL8571700 | 0.73 | NPC1 (0.39) | NPC1RAB9AMAPK1SMN1; SMN2LMNA | |
| SCHEMBL19010378 | 0.72 | NPC1 (0.50) | NPC1RAB9AMAPK1SMN1; SMN2LMNA | |
| SCHEMBL19689000 | 0.70 | MAPK1 (0.48) | NPC1RAB9AMAPK1SMN1; SMN2LMNA | |
| SCHEMBL15457978 | 0.69 | NPC1 (0.47) | NPC1RAB9AMAPK1SMN1; SMN2LMNA | |
| SCHEMBL29445524 | 0.69 | NPC1 (0.47) | NPC1RAB9AMAPK1SMN1; SMN2LMNA | |
| SCHEMBL29445525 | 0.69 | NPC1 (0.47) | NPC1RAB9AMAPK1SMN1; SMN2LMNA | |
| SCHEMBL24147138 | 0.68 | TDP1 (0.42) | NPC1RAB9AMAPK1SMN1; SMN2LMNA | |
| SCHEMBL16158368 | 0.68 | MAPT (0.39) | NPC1RAB9AMAPK1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1312598-B1 | Process for producing aldehyde | MITSUBISHI CHEM CORP (JP) | 2005-02-16 | — | — | EP | disclosed |
| EP-1008581-B1 | Process for producing aldehyde | MITSUBISHI CHEM CORP (JP) | 2004-04-21 | — | — | EP | disclosed |
| US-6610891-B1 | Reduces degradation or decomposition of catalyst | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-08-26 | — | — | US | disclosed |
| US-6583324-B2 | By hydroformylation with rhodium complex catalyst containing an organic phosphite ligand; preventing catalyst poisoning by having the aldehyde remain in the catalyst solution in the separation step | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-06-24 | — | — | US | disclosed |
| EP-1312598-A1 | Process for producing aldehyde | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-05-21 | — | — | EP | disclosed |
| US-20020049355-A1 | Process for producing aldehyde | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-04-25 | — | — | US | disclosed |
| US-6291717-B1 | REACTING OLEFINIC COMPOUND WITH CARBON MONOXIDE AND HYDROGEN IN THE PRESENCE OF A RHODIUM COMPLEX CATALYST COMPRISING RHODIUM AND ORGANIC PHOSPHITE IN REACTION ZONE; SEPARATING CATALYST AND ALDEHYDE; RECYCLING CATALYST SOLUTION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2001-09-18 | — | — | US | disclosed |
| EP-1008581-A1 | Process for producing aldehyde | MITSUBISHI CHEMICAL CORPORATION (JP) | 2000-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049355-A1 | Process for producing aldehyde | ALDH2, OGDH, HAO2 | NPC1 3305/4885RAB9A 1431/4885MAPK1 3949/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.